GlaxoSmithKline plc is a pharmaceutical company focusing on the research, development, and production of medicines, vaccines, and consumer healthcare products. With a rich history dating back to 1929, the company strives to provide solutions for infectious diseases, oncology, immuno-inflammation, respiratory problems, and rare diseases. Their product range includes pediatric, adolescent, adult, and travel vaccines; medicines for acute and chronic diseases; over-the-counter medicines; and wellness, oral health, nutrition, and skin health products. Emma N. Walmsley serves as the CEO of the company.
Headquartered in Philadelphia, Pennsylvania, Glaxosmithkline has additional locations in Research Triangle Park, North Carolina, and Warren, New Jersey. The company is known for its diverse workforce, with 47.8% female and 40.9% ethnic minorities represented. Despite the political imbalance in its demographics favoring the Democratic Party, GlaxoSmithKline maintains a high employee retention rate with staff members staying with the company for an average of 7.6 years. As a pharmaceutical industry leader, GlaxoSmithKline boasts an impressive annual revenue of $34.1 billion and employs approximately 99,000 associates worldwide.